Debbie Wasserman Schultz actually said...

As a breast cancer survivor, the exceptionally high cost of cancer drugs is an issue where the policy is very personal for me.

I think that is really more hope than science.

We should have an honest debate about how many drugs we are willing to give up if we are going to see prices go down.

No one should be unable to afford life-saving medication, but 42 percent of cancer patients deplete their entire net worth.